GlassScriptPhysician profile
Catherine A Taliani
NPI 1992192322
$3,033.50
in general payments reported to CMS, 2019-2025
30 companies · $406 in 2025
The $406 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.76 · 2020: $172 · 2021: $555 · 2022: $738 · 2023: $502 · 2024: $620 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,527.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $367.53 | 2020-2025 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $299.86 | 2021-2025 | |
| Agile Therapeutics, INC. | $260.34 | 2021-2024 | Twirla |
| Sumitomo Pharma America, INC. | $232.73 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $217.50 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $170.72 | 2020-2025 | Slynd |
| Evofem Biosciences, INC. | $147.97 | 2021-2022 | |
| Organon LLC | $143.42 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $126.45 | 2019-2024 | Gardasil, Gardasil 9 |
| Hologic Sales and Service, LLC | $124.61 | 2020-2025 | Aptima, Thinprep 2000 Processor, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Biogen, INC. | $105.19 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $95.83 | 2021-2025 | |
| Aspira Women'S Health INC | $94.77 | 2021-2022 | |
| Coopersurgical, INC. | $85.19 | 2022-2025 | Paragard T 380a |
| Gynesonics, INC. | $66.64 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $63.97 | 2020-2023 | |
| Therapeuticsmd, INC. | $63.38 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $48.81 | 2021 | |
| Minerva Surgical, INC | $45.28 | 2021-2023 | |
| Millicent US INC | $37.30 | 2024-2025 | Femlyv, Intrarosa |
| Vertical Pharmaceuticals, LLC | $35.50 | 2019-2020 | |
| Exact Sciences Corporation | $32.22 | 2024 | Cologuard Collection Kit |
| Dexcom, INC. | $31.59 | 2025 | Dexcom G6 Transmitter |
| Optumhealth Care Solutions, LLC | $30.58 | 2023-2024 | Vivify Health Care Team Portal 001, Eitan Medical, Vivify Health Care Team Portal |
| Shield Therapeutics INC | $29.63 | 2025 | |
| Becton, Dickinson and Company | $20.20 | 2024 | Bd Onclarity |
| Myovant Sciences INC. | $18.39 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.49 | 2019 | |
| Lupin INC. | $13.00 | 2021 | |
| Avion Pharmaceuticals | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Taliani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.